News in brief
PEOPLE ON THE MOVE
30-Apr-2015 - Kaare Schultz, Novo Nordisk Chief Operating Officer and planned successor as Chief Executive, resigned unexpectedly today. Plus FDA's ex-top scientist heads up US Pharmacopoeia.
30-Apr-2015 - As the cost of clinical trials continues to grow, Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA told Senators earlier this week that there are “ways to greatly improve clinical trial efficiency,” and cut costs through the use of master protocols and real-world data.
EBG BIOSIMILARS 2015
29-Apr-2015 - Extra clinical studies are often not needed to license biosimilars for all the same indications as an originator biologic, the EMA and FDA agree.
29-Apr-2015 - Japan’s membership of the PIC/S international inspection and manufacturing scheme bodes well for patients in Japan and elsewhere according to the MHLW.
28-Apr-2015 - Drug companies that want to support aid efforts in Nepal should donate cash rather than medicines according to the World Health Organisation (WHO).
28-Apr-2015 - Hospira has recalled one lot of the anaesthetic Bupivacaine after a customer discovered orange and black particles floating and embedded in a glass vial.
News from CPhI Japan
28-Apr-2015 - ‘Epoch making’ revisions to Japanese drug laws have provided a pathway for development of safer, more innovative drugs according to MHLW director, Haruo Akagawa.